Effect of trans-cranial near infrared light 1068 nm upon age-related memory status: a pilot study.

Gordon Dougal,Abdel Ennaceur,Paul Chazot

DOI: https://doi.org/10.21203/rs.2.15537/v1

2019-10-03

Abstract:Abstract Background We present a pilot study of the Cerebrolite technology, where we explored the effect of multi-modality photo-biomodulation (PBM) therapy, with a peak wavelength of 1068 nm, upon motor function, memory and processing speed reversal in aged individuals who have been diagnosed with mild cognitive impairment (MCI) .Methods PBM therapy was performed at home, adopting the Cerebrolite Trans-cranial phototherapy device, an air-cooled light emitting diode LED pulse mounted inside the helmet, with a peak wavelength of 1068 nm, used for 6 min twice daily on age-matched middle-aged subjects. The FDA- approved computerised assessment tool ANAM was adopted to quantify a series of cognitive and motor activities in the treated groups.Results A significant improvement in motor function, memory and processing speed was observed in MCI aged individuals with PBM- compared to placebo-treated group. No adverse effects were reported.Conclusions PBM therapy may be a promising new non-invasive approach for middle-aged individuals with MCI.